MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 137.8 SAR | -1.43% |
|
-4.83% | 0.00% |
| 19/05 | Avalon Pharma Swings to Profit in Q1; Revenue Down | MT |
| 06/05 | Avalon Pharma Secures Regulatory Nod for Second Production Facility in Saudi Arabia | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Companyâs activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
139.8
SAR
Average target price
107
SAR
Spread / Average Target
-23.46%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 746M | |
| +21.63% | 44.12B | |
| +22.99% | 22.71B | |
| +18.22% | 15.15B | |
| +12.66% | 13.61B | |
| +60.18% | 13.34B | |
| -8.35% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.63B |
- Stock Market
- Equities
- 4016 Stock
- News Middle East Pharmaceutical Industries Company
- Avalon Pharma Secures Regulatory Nod for Second Production Facility in Saudi Arabia
